April 2009
Volume 50, Issue 13
ARVO Annual Meeting Abstract  |   April 2009
Mammalian Target of Rapamycin Signaling in Regulation of Aging of Human RPE
Author Affiliations & Notes
  • Y. Chen
    Ophthalmology, Vanderbilt Univ Med Ctr, Nashville, Tennessee
  • J. Cai
    Ophthalmology, Vanderbilt Univ Med Ctr, Nashville, Tennessee
  • P. Sternberg
    Ophthalmology, Vanderbilt Univ Med Ctr, Nashville, Tennessee
  • Footnotes
    Commercial Relationships  Y. Chen, None; J. Cai, None; P. Sternberg, None.
  • Footnotes
    Support  a Postdoctoral Scholar Award from International Retina Research Foundation, American Health Association Foundation, NIH grant EY07892 and Research to Prevent Blindness, Inc.
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 4181. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Y. Chen, J. Cai, P. Sternberg; Mammalian Target of Rapamycin Signaling in Regulation of Aging of Human RPE. Invest. Ophthalmol. Vis. Sci. 2009;50(13):4181.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Mammalian target of rapamycin (mTOR) is an important sensor of growth factors and nutrients; and regulates cell growth and proliferation. The mTOR controls the process of aging, which is a well-defined risk factor of atrophic AMD. The purposes of this study were to characterize the mTOR signaling network in cultured human retinal pigmental epithelium (RPE) cells and to explore its potential roles in RPE aging.

Methods: : Primary human RPE cells and an immortalized ARPE-19 cell line were used for the study. The expression of major components of mTOR pathways were detected by RT-PCR and Western blot analyses. Formation of the two mTOR signaling complexes, mTORC1 and mTORC2, were determined by co-immunoprecipitation. The mTORC1 activity was assessed by measuring the phosphorylation status of its downstream effector proteins. The in vitro aging of human RPE was determined by measuring the senescence associated β-galactosidase activity.

Results: : The mTOR pathway responded to various upstream stimuli in a rapamycin-sensitive manner. FKBP8, a newly identified endogenous mTOR inhibitor, exerted its inhibitory functions on mTOR signaling in the RPE. The prototypic mTOR inhibitor Rapamycin inhibited the senescent phenotype of cultured human RPE cells.

Conclusions: : RPE cells have functional mTOR signaling network. Delaying aging of the RPE by regulating mTOR signaling can be a potential therapeutic option for degenerative changes associated with atrophic AMD.

Keywords: age-related macular degeneration • aging • signal transduction 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.